Syndromic Surveillance in California

Syndromic Surveillance in California One state's less-than-stellar experience tracking disease By Katherine Eban ARTICLE EXTRAS Biosense or Biononsense? As spinach tainted with a deadly Escherichia coli made its way last year from a California farm through 26 states, sickening more than 200 people and killing three, a bill to advance symptom mo

Written byKatherine Eban
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

One state's less-than-stellar experience tracking disease
By Katherine Eban

ARTICLE EXTRAS

Biosense or Biononsense?


As spinach tainted with a deadly Escherichia coli made its way last year from a California farm through 26 states, sickening more than 200 people and killing three, a bill to advance symptom monitoring was making far slower progress through the California state bureaucracy. To some public-health experts, it was déjà vu all over again, on two counts: a tidal wave of symptoms that no one saw, until it was too late; and a possible solution encountering bureaucratic resistance.

Since 2003, two statewide commissions on emergency preparedness had advised that California urgently needed electronic systems for syndromic surveillance and disease reporting. A report by the Little Hoover Commission in 2003 noted that in California, only one-fifth of "reportable" diseases and conditions are actually reported to public health officials. "When a California food processor" - Odwalla ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies